143 related articles for article (PubMed ID: 35348280)
1. Differentiation Between Lipomas and Atypical Lipomatous Tumors of the Extremities Using Radiomics.
Tang Y; Cui J; Zhu J; Fan G
J Magn Reson Imaging; 2022 Dec; 56(6):1746-1754. PubMed ID: 35348280
[TBL] [Abstract][Full Text] [Related]
2. Tumor-to-bone distance and radiomic features on MRI distinguish intramuscular lipomas from well-differentiated liposarcomas.
Sudjai N; Siriwanarangsun P; Lektrakul N; Saiviroonporn P; Maungsomboon S; Phimolsarnti R; Asavamongkolkul A; Chandhanayingyong C
J Orthop Surg Res; 2023 Mar; 18(1):255. PubMed ID: 36978182
[TBL] [Abstract][Full Text] [Related]
3. Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods.
Liu J; Zeng P; Guo W; Wang C; Geng Y; Lang N; Yuan H
J Magn Reson Imaging; 2021 Oct; 54(4):1303-1311. PubMed ID: 33979466
[TBL] [Abstract][Full Text] [Related]
4. Radiomics Nomograms Based on Non-enhanced MRI and Clinical Risk Factors for the Differentiation of Chondrosarcoma from Enchondroma.
Pan J; Zhang K; Le H; Jiang Y; Li W; Geng Y; Li S; Hong G
J Magn Reson Imaging; 2021 Oct; 54(4):1314-1323. PubMed ID: 33949727
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging based on radiomics for differentiating T1-category nasopharyngeal carcinoma from nasopharyngeal lymphoid hyperplasia: a multicenter study.
Cheng J; Su W; Wang Y; Zhan Y; Wang Y; Yan S; Yuan Y; Chen L; Wei Z; Zhang S; Gao X; Tang Z
Jpn J Radiol; 2024 Feb; ():. PubMed ID: 38409300
[TBL] [Abstract][Full Text] [Related]
7. An MRI-Based Radiomics Nomogram to Assess Recurrence Risk in Sinonasal Malignant Tumors.
Wang T; Hao J; Gao A; Zhang P; Wang H; Nie P; Jiang Y; Bi S; Liu S; Hao D
J Magn Reson Imaging; 2023 Aug; 58(2):520-531. PubMed ID: 36448476
[TBL] [Abstract][Full Text] [Related]
8. Radiomics analysis of T1WI and T2WI magnetic resonance images to differentiate between IgG4-related ophthalmic disease and orbital MALT lymphoma.
Shao Y; Chen Y; Chen S; Wei R
BMC Ophthalmol; 2023 Jun; 23(1):288. PubMed ID: 37353736
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Multiparametric MRI-Based Radiomics Analysis for the Diagnosis of Breast Phyllodes Tumors.
Ma X; Gong J; Hu F; Tang W; Gu Y; Peng W
J Magn Reson Imaging; 2023 Feb; 57(2):633-645. PubMed ID: 35657093
[TBL] [Abstract][Full Text] [Related]
10. MRI radiomics-based machine learning for classification of deep-seated lipoma and atypical lipomatous tumor of the extremities.
Gitto S; Interlenghi M; Cuocolo R; Salvatore C; Giannetta V; Badalyan J; Gallazzi E; Spinelli MS; Gallazzi M; Serpi F; Messina C; Albano D; Annovazzi A; Anelli V; Baldi J; Aliprandi A; Armiraglio E; Parafioriti A; Daolio PA; Luzzati A; Biagini R; Castiglioni I; Sconfienza LM
Radiol Med; 2023 Aug; 128(8):989-998. PubMed ID: 37335422
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging-Based Radiomics Nomogram for Prediction of the Histopathological Grade of Soft Tissue Sarcomas: A Two-Center Study.
Yan R; Hao D; Li J; Liu J; Hou F; Chen H; Duan L; Huang C; Wang H; Yu T
J Magn Reson Imaging; 2021 Jun; 53(6):1683-1696. PubMed ID: 33604955
[TBL] [Abstract][Full Text] [Related]
12. [Radiomics models based on non-enhanced MRI can differentiate chondrosarcoma from enchondroma].
Pan J; Jiang Y; Zhan Y; Zuo P; Fang Y; Li S; Hong G
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):483-490. PubMed ID: 32895139
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing brain inflammation from grade II glioma in population without contrast enhancement: a radiomics analysis based on conventional MRI.
Han Y; Yang Y; Shi ZS; Zhang AD; Yan LF; Hu YC; Feng LL; Ma J; Wang W; Cui GB
Eur J Radiol; 2021 Jan; 134():109467. PubMed ID: 33307462
[TBL] [Abstract][Full Text] [Related]
14. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
[TBL] [Abstract][Full Text] [Related]
15. Radiomics nomogram for differentiating between benign and malignant soft-tissue masses of the extremities.
Wang H; Nie P; Wang Y; Xu W; Duan S; Chen H; Hao D; Liu J
J Magn Reson Imaging; 2020 Jan; 51(1):155-163. PubMed ID: 31169956
[TBL] [Abstract][Full Text] [Related]
16. Developing a clinical scoring system to differentiate deep-seated atypical lipomatous tumor from lipoma of soft tissue.
Cheng Y; Ko AT; Huang JH; Lee BC; Yang RS; Liang CW; Tai HC; Cheng NC
Asian J Surg; 2019 Aug; 42(8):832-838. PubMed ID: 30711441
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of lipoma from atypical lipomatous tumor/well-differentiated liposarcoma using magnetic resonance imaging radiomics combined with machine learning.
Cay N; Mendi BAR; Batur H; Erdogan F
Jpn J Radiol; 2022 Sep; 40(9):951-960. PubMed ID: 35430677
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response to preoperative neoadjuvant chemotherapy in extremity high-grade osteosarcoma using X-ray and multiparametric MRI radiomics.
Luo Z; Li J; Liao Y; Huang W; Li Y; Shen X
J Xray Sci Technol; 2023; 31(3):611-626. PubMed ID: 37005907
[TBL] [Abstract][Full Text] [Related]
20. Radiomics-based approaches outperform visual analysis for differentiating lipoma from atypical lipomatous tumors: a review.
Haidey J; Low G; Wilson MP
Skeletal Radiol; 2023 Jun; 52(6):1089-1100. PubMed ID: 36385583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
